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Edited by Maurice MontalAbstract Since cannabinoid receptors inhibit excitatory synap-
tic transmission by reducing glutamate release, we have exam-
ined whether this might occur through the direct inhibition of
presynaptic Ca2+ channels. In cerebrocortical nerve terminals,
activation of cannabinoid receptors with WIN55,212-2 reduces
the KCl-evoked release of glutamate. However, this inhibition
is attenuated when N- and P/Q-type Ca2+ channels are blocked.
Through Ca2+ imaging in single nerve terminals, we found that
WIN55,212-2 reduced the inﬂux of Ca2+ both in nerve terminals
that contain N-type Ca2+ channels and those that contain P/Q-
type Ca2+ channels. Thus, cannabinoid receptors modulate the
two major Ca2+ channels coupled to glutamate release in the
cerebral cortex.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Endocannabinoids released by postsynaptic cells inhibit neu-
rotransmitter release by activating presynaptic cannabinoid
receptors in many synapses, including those in the cerebral cor-
tex [1–6]. It has been suggested that inhibition of presynaptic
Ca2+ channels is responsible for the reduction of glutamate
release by cannabinoid receptors. However, it has not been
clearly established which types of Ca2+ channel can be modu-
lated by this presynaptic mechanism. In cultured rat hippo-
campal neurons, cannabinoids inhibit somatic N- and
P/Q-type calcium channels [7]. However, studies of synaptic
transmission have indicated a selective inhibition of N-type
Ca2+ channels, since blockage of these Ca2+ channels subtype
with toxins suppresses the response to cannabinoids [1,8,9].
Direct measurement of the eﬀects of cannabinoid on presyn-
aptic Ca2+ channels has been limited to synapses with a large
presynaptic bouton like those at the Calyx of Held [10]. How-
ever, monitoring the presynaptic Ca2+ inﬂux and measuring
the postsynaptic current amplitude in brain slices reﬂect the
activation of many synaptic terminals that may or may not ex-
press the presynaptic receptor under study [11]. Here, we have
used a preparation of cerebrocortical nerve terminals to deter-
mine the eﬀect that cannabinoids have on glutamate release. In*Corresponding author. Fax: +34 91 394 39 09.
E-mail address: jsprieto@vet.ucm.es (J. Sa´nchez-Prieto).
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doi:10.1016/j.febslet.2004.12.065addition, by imaging Ca2+ in individual nerve terminals we
determined the impact that the activation of cannabinoid
receptors has on the Ca2+ response evoked by depolarization,
identifying the type of Ca2+ channel involved. The results show
that cannabinoid receptors reduce the depolarization-induced
inﬂux of Ca2+ in nerve terminals that contain N- or P/Q-type
of Ca2+ channels. As a consequence, they reduce the glutamate
release component associated with the activation of these two
Ca2+ channels.2. Materials and methods
2.1. Synaptosomal preparation
The cerebral cortex was isolated from adult male Wistar rats (2–3
months) and the synaptosomes were puriﬁed as described previously
[12,13] on discontinuous Percoll gradients (Amersham–Pharmacia Bio-
tech, Uppsala, Sweden). Following the ﬁnal centrifugation at
22000 · g for 10 min, the synaptosomes were resuspended in 8 ml of
HEPES buﬀer medium (HBM): 140 mM NaCl, 5 mM KCl, 5 mM
NaHCO3, 1.2 mM NaH2PO4, 1 mM MgCl2, 10 mM glucose and
10 mM HEPES, pH 7.4. The protein content was determined by the
Biuret method, and 1 mg of the synaptosomal suspension was diluted
in 8 ml of HBM and spun at 3000 · g for 10 min. The supernatant was
discarded and the pellet containing the synaptosomes was stored on
ice. Under these conditions, the synaptosomes remain fully viable for
at least 4–6 h, as judged by the extent of KCl evoked glutamate release.
2.2. Glutamate release
Glutamate release was assayed by on-line ﬂuorimetry. Synaptosomal
pellets were resuspended in HBM (0.67 mg/ml) and preincubated at
37 C for 1 h in the presence of 16 lM bovine serum albumin (BSA).
The BSA served to bind any free fatty acids released from synapto-
somes during the preincubation. A 1 ml aliquot was transferred to a
stirred cuvette and the release of glutamate was measured as previously
described [14]. The Ca2+-dependent release was calculated by subtract-
ing the release obtained during a 5 min period of depolarization in the
presence of 200 nM free [Ca2+] from the release at 1.33 mM CaCl2.
2.3. Plasma membrane potential
The plasma membrane potential was determined with 3,3 0-dipropyl-
thiadicarbocyanine iodide, DiSC3(5). Synaptosomes were resuspended
(0.67 mg/ml) in HBM without BSA, and 1 ml aliquots were transferred
to a stirred cuvette containing 5 lM DiSC3(5) and 1.33 mM CaCl2.
After allowing the mixture to equilibrate for 1 min, the ﬂuorescence
was determined at 651 and 675 nm. Data were collected at 1 s intervals.2.4. Ca2+ imaging of the responses in single synaptosomes
Synaptosomes in HBM (2 mg/ml) with 16 lM BSA were preincu-
bated with 5 lM fura-2 AM and 1.33 mM CaCl2 for 40 min and the
synaptosomal suspension was then attached to a polylysine-coated
coverslip for another hour. Synaptosomes were illuminated alternately
at 340 and 380 nm for 0.8 s through a 100· objective with the aid of a
monochromator (Kinetic Imaging, Ltd., UK). The ﬂuorescence emit-
ted from the nerve terminals was collected through a band-pass ﬁlterblished by Elsevier B.V. All rights reserved.
M.C. Godino et al. / FEBS Letters 579 (2005) 768–772 769centered at 510 nm and images were obtained using a slow-scan CCD
camera (Hamamatsu C4880) operating at 12-bit digitalization (4096
levels). The output from the camera was stored by the computerized
imaging system Lucida 3.0 (Kinetic Imaging, Ltd.) and Ca2+ images
were analyzed as described previously [15]. To measure [Ca2+]cyt, syn-
aptosomes were stimulated by 10 s pulses of 30 mM KCl (a bar in each
graph) in the presence or absence of pharmacological agonists or Ca2+
channels toxins.3. Results
3.1. WIN55,212-2 reduces the glutamate release components
associated with N- and P/Q-type Ca2+ channels
Depolarization of nerve terminals with KCl opens Ca2+
channels and initiates the exocytotic release of glutamate.
The Ca2+-dependent release of glutamate after 5-min depolar-
ization with KCl was 3.66 ± 0.16 nmol/mg of protein (n = 5;
Fig. 1A). The prior addition of the cannabinoid receptor ago-
nist WIN55,212-2 reduced the release by 37.4 ± 4.3% (n = 4;
Fig. 1A). The inhibition by WIN55,212-2 of the KCl-induced
release was almost completely abolished (2.4% ± 3.5, n = 3,
data not shown) by the cannabinoid receptor antagonist
AM281 (1 lM). Treatment of synaptosomes with pertussis
toxin abolished (0.56 ± 5.5%, n = 3, data not shown) the inhi-
bition of release by WIN55,212-2. The blockade of Na+ chan-
nels with tetrodotoxin (TTx) did not alter (37.1 ± 2.1%, n = 3,
Fig. 1A) the inhibition of release by cannabinoids excluding
the modulation of voltage dependent K+ channels associated
to action potentials. Furthermore, depolarization of the synap-
tosomal plasma membrane measured with a membrane poten-
tial-sensitive cationic cyanide dye was not modiﬁed by
WIN55,212.2. Thus, the increase in ﬂuorescence induced
by 30 mM KCl (57.0 ± 2.4 arbitrary units) was not altered
by WIN55,212-2 (55.1 ± 4.3 a.u., n = 5, data not shown). In
order to know to what extent this inhibition resulted from a
reduction in the activity of Ca2+ channels coupled to glutamate
exocytosis, we performed experiments in the presence of Ca2+Fig. 1. WIN55,212-2 reduces the release components associated with N- an
evoked by 30 mMKCl in the presence and absence (control) of 5 lMWIN55,
(x-CgT-GVIA). WIN55,212-2 and the Ca2+ channel toxins were added 5 and
the Ca2+-dependent release of glutamate 5 min after depolarization with 30
toxins x-CgT-GVIA and x-Aga-IVA, both in the presence and absence of W
Na+ channel blocker (1 lM) was added 1 min prior to depolarization with 30
from the same number of synaptosomal preparations.channel toxins. In cerebrocortical nerve terminals, glutamate
release is primarily coupled to Ca2+ entry through both N-
and P/Q-type Ca2+ channels [15,16], channels that can be selec-
tively blocked by x-CgTx-GVIA [17] and x-Aga-IVA [18],
respectively. Blocking N-type channels with x-CgTx-GVIA re-
duced the KCl-evoked release by 30.8 ± 2.6% (n = 3) and par-
tially occluded the inhibition by WIN55,212-2 (17.2 ± 3.8%,
n = 5, Fig. 1A and B). Blocking P/Q-type Ca2+ channels with
x-Aga-IVA reduced glutamate release by 65.5 ± 1.3% (n = 4,
Fig. 1A and B) and also partially occluded the inhibition of re-
lease by WIN55,212-2 in this case by 20.9 ± 2.0% (n = 4; Fig.
1B). Thus, these data indicate that cannabinoid receptors inhi-
bit glutamate release coupled to both the P/Q- and the N-type
Ca2+ channels.
3.2. WIN55,212-2 reduces the entry of Ca2+ in nerve terminals
containing N- or P/Q-type Ca2+ channels
To further examine whether cannabinoid receptors reduce
the activity of Ca2+ channels, we visualized Ca2+ in single
nerve terminals. We have previously shown that the two major
subpopulations of cerebrocortical nerve terminals exist, con-
taining N- or P/Q-types of Ca2+ channels [19]. In these exper-
iments, nerve terminals were ﬁrst stimulated with KCl in the
presence of either x-CgTx-GVIA to block N-type channels
or x-Aga-IVA to block P/Q-type channels. Subsequently,
KCl was added in the presence of the cannabinoid agonist
WIN55,212-2 and ﬁnally KCl was added alone. In the experi-
ments with x-CgTx-GVIA and WIN55,212-2 (Fig. 2), a total
of 812 nerve terminals from ﬁve ﬁelds were analyzed. In a sub-
population of nerve terminals (9.3 ± 0.5%), the Ca2+ responses
were reduced by x-CgTx-GVIA but not by WIN55,212-2, indi-
cating the presence of N-type channels but the absence of
WIN55,212-2-sensitive receptors modulating Ca2+ entry. In
another subpopulation of nerve terminals (22.5 ± 1.4%),
Ca2+ responses were insensitive to x-CgTx-GVIA but they
were reduced by exposure to WIN55,212-2, indicating the pres-
ence of WIN55,212-sensitive cannabinoid receptors but not ofd P/Q-type Ca2+ channels. (A) Ca2+-dependent release of glutamate
212-2 (WIN), 200 nM x-Aga-IVA (x-Aga-IVA) or 2 lM x-CgT-GVIA
1 min prior to depolarization with 30 mMKCl. (B) Bar diagrams show
mM KCl in the presence and absence (Control) of the Ca2+-channels
IN55,212-2 (5 lM). In the experiments with tetrodotoxin (TTX), the
mM KCl. The results are means ± SEM of 3–5 experiments obtained
Fig. 2. Ca2+ responses are reduced by both x-CgT-GVIA and WIN55,212-2 in a subpopulation of nerve terminals. Synaptosomes were ﬁxed onto
polylysine coated coverslips and loaded with fura-2 as indicated in Section 2. (A) Representative ﬁeld of fura-2-loaded synaptosomes under basal
conditions at 380 nm. Ca2+ responses induced by a 10 s application of 30 mM KCl were determined in the presence of 2 lM x-CgT-GVIA, (x-CgT-
GVIA+KCl) and in the presence of 10 lMWIN55,212-2 (WIN + KCl). Control Ca2+ responses were induced by 30 mMKCl in the absence of toxins
(KCl) at the end of the experiment. Individual responses of the subpopulation of nerve terminals that only responded to x-CgT-GVIA (B; n = 3),
WIN55,212-2 (C; n = 3) or to both x-CgT-GVIA and WIN55,212-2 (D; n = 3). (E) Individual responses of the subpopulation of nerve terminals that
did not respond to either x-CgT-GVIA or WIN55,212-2 (n = 5). The results are means ± SEM and (n) indicates the number of individual responses.
The disc diagram inserted in black indicates the % of nerve terminals showing a given response.
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(28.8% ± 4.5), Ca2+ responses were reduced both by x-CgTx-
GVIA and WIN55,212 revealing the presence of cannabinoid
receptors and N-type Ca2+ channels in individual nerve termi-
nals. Finally, 39.0 ± 2.3% of the synaptic boutons were insen-
sitive to both x-CgTx-GVIA and WIN55,212.
In another set of experiments, nerve terminals were stimu-
lated in the presence of x-Aga-IVA to block P/Q-type Ca2+
channels. A total of 455 nerve terminals from four ﬁelds were
analyzed. This identiﬁed nerve terminals whose Ca2+ responses
were inhibited only by x-Aga-IVA (36.7 ± 10.8%) and another
subpopulation of nerve terminals in which the Ca2+ responses
were only reduced by WIN55,212-2 (27.2 ± 4.1%). Terminals
in which Ca2+ entry was blocked both by x-Aga-IVA and
WIN55,212-2, and in which both P/Q-type Ca2+ channelsand cannabinoid receptors are therefore present represented
27.0 ± 3.5% of the total population. Finally, in some nerve ter-
minals (8.8 ± 2.2%) Ca2+ responses were insensitive to x-Aga-
IVA and to WIN55,212-2.4. Discussion
In this study, we show that the activation of cannabinoid
receptors inhibits glutamate release in the whole population
of cerebrocortical nerve terminals and that this eﬀect can be
partially occluded by blocking N- and P/Q-types of Ca2+ chan-
nels. Ca2+ imaging experiments of individual nerve terminals
indicate that cannabinoid receptors reduce the inﬂux of Ca2+
in a subset of nerve terminals that express either N- or P/Q-
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which cannabinoid receptors inhibit glutamate release in the
cerebral cortex may involve the inhibition of the two major
Ca2+ channels that trigger release.
A number of studies have suggested that blocking Ca2+
channels is responsible for the inhibition of synaptic transmis-
sion by cannabinoid receptors, but only a few studies have di-
rectly measured the activity of presynaptic channels [10,11].
We have found that the inhibition of glutamate release by can-
nabinoid receptors is partially occluded by blocking N- and
P/Q-type Ca2+ channels with x-CgTx-GVIA and x-
Aga-IVA, respectively. This suggests that cannabinoid recep-
tors reduce Ca2+ channel activity in some but not in all nerve
terminals expressing N- or P/Q-type Ca2+ channels. We cor-
roborated this proposal by imaging Ca2+ in synaptosomes that
were blocked by x-CgTx-GVIA or x-Aga-IVA and that were
sensitive or insensitive to WIN55,212-2. These experiments
provide evidence that the Ca2+ channels were directly modu-
lated by cannabinoid receptors. Cannabinoid receptors also
modulate K+ channels and thus, they can indirectly reduce
Ca2+ channels activity and the subsequent release of glutamate
[20]. Nevertheless, it is unlikely that K+ channels are activated
during KCl-evoked responses in nerve terminals due to the high
external K+ concentration. In addition, KCl-evoked responses
are insensitive to the Na+-channels blocker tetrodotoxin [19,21]
and, therefore, it seems more likely that the inhibitory receptors
target release-coupled Ca2+ channels rather than ionic channels
involved in the waveform of action potentials.Fig. 3. Ca2+ responses are reduced both by x-AGA-IVA andWIN55,212-2 in
KCl were determined in the presence of 200 nM x-AGA-IVA (x-AGA-IV
Control Ca2+ responses were induced by 30 mM KCl in the absence of to
subpopulation of nerve terminals that only responded to x-AGA-IVA (A
WIN55,212-2 (C; n = 11). (D) Individual responses of the subpopulation
WIN55,212-2 (n = 8). The results are means ± SEM and (n) indicates the num
the % of nerve terminals showing a given response.The N- and P/Q-types of Ca2+ channels are segregated
among diﬀerent populations of nerve terminals in the cerebral
cortex of adult rats [20]. The ﬁnding that cannabinoid recep-
tors inhibit both types of Ca2+ channels suggests that they
inﬂuence the activity of those Ca2+ channels with which they
are co-expressed rather than selectively acting on the signaling
pathways speciﬁc to a subtype of Ca2+ channels. Similar re-
sults were obtained in a recent study in the cerebellum where
the three types of Ca2+ channels (N, P/Q and R) present in
granule cell presynaptic boutons were inhibited by cannabi-
noid receptors [11]. In contrast, our results do not agree with
the selective regulation of N-type Ca2+ channels by cannabi-
noid receptors in the hippocampus [8], striatal neurons [1]
and in trigeminal caudal neurons [9]. In these preparations,
cannabinoid-mediated inhibition of excitatory synaptic trans-
mission was eliminated by pre-treatment with antagonists of
N-type Ca2+ channels.
Cannabinoid agonists inhibit the Ca2+-dependent release by
37.43 ± 1.3%, whereas Ca2+ imaging experiments show that
cannabinoid receptors reduced the inﬂux of Ca2+ in 51–54%
of the nerve terminals. If cannabinoid receptors were restricted
to glutamatergic nerve terminals these data would indicate that
cannabinoid receptors do not exert complete control over glu-
tamate release, in spite of the signiﬁcant reduction of Ca2+ in-
ﬂux (Figs. 2C and 3C). However, this possibility is rather
unlikely given the high local [Ca2+]c that triggers release [22],
since a reduction in Ca2+ entry would prevent the ﬁring of
those nerve terminals expressing the receptor. Alternatively,a subpopulation of nerve terminals. Ca2+ responses induced by 30 mM
A + KCl) and in the presence of 10 lM WIN55,212-2 (WIN + KCl).
xins at the end of the experiment (KCl). Individual responses of the
; n = 6), to WIN55,212-2 (B; n = 8), or to both x-AGA-IVA and
of nerve terminals that did not respond to either x-AGA-IVA or
ber of individual responses. The disc diagram inserted in black indicates
772 M.C. Godino et al. / FEBS Letters 579 (2005) 768–772Ca2+ imaging may detect the eﬀects of cannabinoids on
GABAergic nerve terminals as well as on glutamatergic nerve
terminals explaining the increased sensitivity of this technique.
We have previously shown that GABAergic nerve terminals
represent a fraction of 24% in the cerebrocortical preparation
[20]. Furthermore, cannabinoid receptors are known to be ex-
pressed in GABAergic nerve terminals where they reduce the
release of GABA by a mechanism that involves the inhibition
of Ca2+ channel activity [23].
In summary, we show that the two major types of Ca2+
channels coupled to glutamate release in the cerebral cortex
are modulated by cannabinoid receptors.Acknowledgments: This work was supported by Ministerio de Ciencia
y Tecnologı´a (MCyT) Grant BFI2001-1436 and Direccio´n General de
Investigacio´n de la Comunidad de Madrid Grant 08.5/0008.1/2003. We
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